Operator
Good day, ladies and gentlemen, and welcome to the LivaNova PCL (sic) PLC Second Quarter 2020 (sic) 2021 Earnings Conference Call. [Operator Instructions] I would now like to introduce your host for today s conference, Mr. Matthew Dodds, LivaNova s Senior Vice President of Corporate Development. Please go ahead, sir.
Matthew Dodds
Senior Vice President, Corporate Development
Thank you, Crystal, and welcome to our conference call and webcast discussing LivaNova s financial results for the second quarter of 2021. Joining me on today s call are Danny McDonald, our Chief Executive Officer; Alex Shvartsburg, our Interim Chief Financial Officer, who will be appointed as our Chief Financial Officer, effective August 1; and Lindsey Little, our Senior Director of Investor Relations. Before we begin, I would like to remind you that the discussions during this call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed
LivaNova PLC: LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
LivaNova Sells Heart Valve Business to Gyrus Capital
The LivaNova Percelval sutureless aortic valve and Solo Smart surgical aortic valve are part of heart valve portfolio the company sold off June 1.
June 2, 2021 – LivaNova announced June 1 it successfully completed the initial closing of the divestiture of its heart valve business to the investment firm Gyrus Capital for €60 million ($73 million). Corcym, an independent company recently launched and owned by entities funded and controlled by Gyrus, will manage the heart valve business.
“The completion of the heart valve sale to Gyrus Capital allows LivaNova to optimize its portfolio and sharpen its focus on cardiovascular and neuromodulation, our two areas of excellence,” said Damien McDonald, CEO of LivaNova. “We are now better positioned to accelerate growth in our core, dedicate resources toward executing promising pipeline opportunities, and enhance our operational excellence to best serve our patients and deliver
Additional local business closings to occur later this year LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has successfully completed the